LightSNiP assay is a good strategy for pharmacogenetics test

by Cheli, Stefania, Pietrantonio, Filippo, Clementi, Emilio, Falvella, Felicia S.
Published 2015

BRAF-mutated metastatic colorectal cancer between past and future

by Cremolini, Chiara, Di Maio, Massimo, Petrelli, Fausto, Berenato, Rosa, Loupakis, Fotios, Pietrantonio, Filippo
Published 2015

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

by Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Published 2015

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies

by Iacovelli, Roberto, Pietrantonio, Filippo, Farcomeni, Alessio, Maggi, Claudia, Palazzo, Antonella, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published 2014

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

by Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Published 2014

Role of cMET in the Development and Progression of Colorectal Cancer

by Pérez-Vargas, Juan Carlos Samamé, Biondani, Pamela, Maggi, Claudia, Gariboldi, Manuela, Gloghini, Annunziata, Inno, Alessandro, Volpi, Chiara Costanza, Gualeni, Ambra Vittoria, di Bartolomeo, Maria, de Braud, Filippo, Castano, Alessandra, Bossi, Ilaria, Pietrantonio, Filippo
Published 2013

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

by Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase

by Falvella, Felicia Stefania, Caporale, Marta, Cheli, Stefania, Martinetti, Antonia, Berenato, Rosa, Maggi, Claudia, Niger, Monica, Ricchini, Francesca, Bossi, Ilaria, Di Bartolomeo, Maria, Sottotetti, Elisa, Bernardi, Francesca Futura, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published 2015

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

by Pietrantonio, Filippo, Berenato, Rosa, Maggi, Claudia, Caporale, Marta, Milione, Massimo, Perrone, Federica, Tamborini, Elena, Baratti, Dario, Kusamura, Shigeki, Mariani, Luigi, Niger, Monica, Mennitto, Alessia, Gloghini, Annunziata, Bossi, Ilaria, Settanni, Giulio, Busico, Adele, Bagnoli, Pietro Francesco, Di Bartolomeo, Maria, Deraco, Marcello, de Braud, Filippo
Published 2016

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

by Van Emburgh, Beth O., Arena, Sabrina, Siravegna, Giulia, Lazzari, Luca, Crisafulli, Giovanni, Corti, Giorgio, Mussolin, Benedetta, Baldi, Federica, Buscarino, Michela, Bartolini, Alice, Valtorta, Emanuele, Vidal, Joana, Bellosillo, Beatriz, Germano, Giovanni, Pietrantonio, Filippo, Ponzetti, Agostino, Albanell, Joan, Siena, Salvatore, Sartore-Bianchi, Andrea, Di Nicolantonio, Federica, Montagut, Clara, Bardelli, Alberto
Published 2016